Cephalon Inc  CEPH
What Does This Company Do?
Cephalon is a biopharmaceutical firm that specializes in developing and marketing therapeutics for central nervous system disorders, pain, and cancer. The firm's blockbuster product, Provigil, treats excessive sleepiness. Another leading product, Treanda, treats cancer. Cephalon's other drugs help treat cancer pain, seizures, and muscle spasms. The firm also has a European generics arm via the acquisition of Mepha. In 2010, 76% of sales came from the United States.
Direct Investment No
Dividend Reinvestment No
Employees ---
Become a Morningstar Premium Member. Enjoy our analyst picks and buy-sell opinions on 3,800 stocks, funds and ETFs. Learn more.

© Copyright 2014 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.